The atrial natriuretic peptide (ANP) receptor designated GC-A is a single transmembrane protein that functions as a ligand-activated guanylate cyclase (reviewed in ref. 1 ). This receptor is important in cardiovascular homeostasis; mice lacking the ANP receptor are hypertensive (1) .
Binding of ANP to the extracellular domain of GC-A results in activation of the intracellular guanylate cyclase catalytic domain and production of the second messenger, cyclic GMP (1).
The intracellular portion of the ANP receptor contains, in addition to a cyclase domain, a protein kinase-like domain (1) . This domain lacks protein kinase activity, and its function is incompletely understood. It has an autoinhibitory role, however, repressing cyclase activity in the absence of bound hormone (2, 3) . In the course of our studies of the ANP receptor, which is regulated by phosphorylation, we used the yeast two-hybrid system to identify a protein serine/threonine phosphatase that binds specifically to the kinase-like domain of the receptor (4).
This phosphatase, designated PP5, may mediate ANP receptor desensitization.
Heat shock protein 90 (hsp90) and heat shock protein 70 (hsp70) are molecular chaperones required for the proper folding and trafficking of many proteins involved in signal transduction (5) (6) (7) . In general, this process involves the sequential formation of complexes between newly synthesized proteins and, first, hsp70, then hsp90. A variety of co-chaperones are also present in the complexes with heat shock proteins; which co-chaperones are present depends on the protein being folded. Mature steroid receptor complexes with hsp90, for example, typically contain a large immunophilin and the small acidic protein p23 as co-chaperones. Protein kinase complexes with hsp90, on the other hand, typically contain the co-chaperone designated p50 cdc37 (5-7). The co-chaperones present in the final hsp90 heterocomplex can be critical to the function of the hsp90 client protein. For example, which large immunophilin is present in glucocorticoid receptor•hsp90 complexes determines receptor binding affinity (8, 9) , and p50 cdc37 is required for proper folding of some protein kinases (10) . While the hsp90 folding pathway has been best characterized in studies of the maturation of newly synthesized steroid receptors and protein kinases, a number of other signaling proteins that make use of this pathway have been identified recently (7) . Such discoveries have in large part been made possible by the availability of the drug geldanamycin, which interferes with hsp90 function by blocking its binding site for ATP (11) .
We have previously reported that PP5 binds to hsp90 and is a major component of glucocorticoid receptor•hsp90 heterocomplexes (12, 13) . This raised the question of whether the association of PP5 with the kinase-like domain of the ANP receptor in the yeast two-hybrid system was direct, or whether it might be mediated by the binding of hsp90 to both the ANP receptor and to PP5. We set out, therefore, to test whether the ANP receptor was associated with hsp90 complexes. We report here that the ANP receptor is associated with hsp90 and the cochaperone p50 cdc37 via its kinase-like domain, and that this association is important for its function.
EXPERIMENTAL PROCEDURES
Materials -Geldanamycin was obtained from the Drug Synthesis and Chemistry Branch of the National Cancer Institute. Monoclonal and polyclonal antibodies to cdc37 (14) , and polyclonal antibodies to PP5 (12) A monoclonal antibody to hsc70/hsp70 (SPA-820) was from Stressgen. Antibodies directed against hsp90 (AC-16) and the FLAG epitope (M2) were obtained from Sigma. 125 I-labeled cyclic GMP was obtained from Biochemical Technologies.
Preparation of a stable cell line expressing FLAG-tagged GC-A -293 cells were obtained from
the American Type Culture Collection, and maintained in DME containing 10% fetal bovine serum and 50 µg/ml gentamicin. The previously described FLAG-tagged rat GC-A construct in pSP72 (2) was excised as a SalI/SmaI fragment and subcloned into the SalI/EcoRV sites of pcDNA1/Neo (Invitrogen). The resulting construct, pcDNA1/Neo-FLAG-GC-A, was transfected into 293 cells using Lipofectin (Life Technologies), and stable transfectants were selected by growth in the presence of G418 (750 µg/ml). After isolation with cloning cylinders, individual clones were expanded and screened by metabolic labeling with [ 35 S]methionine/cysteine and immunoprecipitation with the M2 antibody, followed by SDS-PAGE and fluorography as described previously (15) . Several clones were analyzed further by measuring, in intact cells, 125 I-ANP binding and ANP-stimulated production of cyclic GMP, using previously-described methods (2, 15) . The clone having the highest levels of FLAGtagged GC-A, as determined by all three methods, was used in these studies, after subcloning by limiting dilution. Based on 125 I-ANP binding studies, these cells contain approximately 50,000 receptors per cell. Cells were maintained as described above for control 293 cells except that medium was supplemented with 400 µg/ml of G418. Treatment with 1 µM ANP for 10 min at 27° C and radioimmunoassay of cell extracts was then performed as described previously (15) .
Cyclic GMP production in intact cells

Co-immunoprecipitation experiments -Cultures in 10-cm plates were treated for approximately
16 h with the indicated concentrations of geldanamycin or with vehicle (DMSO). Cells were then washed with phosphate-buffered saline and lysed in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 20 mM MoO 4 , 0.09% NP-40, 5 ug/ml leupeptin, and 5ug/ml aprotinin. After clarification of lysates by centrifugation at 15,000 x g for 20 min at 4° C, immunoprecipitation of FLAGtagged proteins was performed using either M2 beads (Sigma) or M2 antibody prebound to antimouse IgG agarose beads, as described previously (12) . After washing five times with the lysis buffer, the beads were heated in SDS sample buffer. In one experiment (Fig. 4 , right panel), the immunoprecipitated proteins were eluted from M2 beads using 200 µg/ml of FLAG peptide (DYKDDDDK) in phosphate-buffered saline in order to reduce background staining of IgG heavy chain. Aliquots of the immunoprecipitates were then subjected to SDS-PAGE and immunoblotting with the indicated antibodies as described previously (12) .
Expression of GC-A deletion mutants -COS-7 cells in 10-cm plates were transfected with the indicated plasmids using the Superfect reagent (Qiagen) according to the manufacturer's instructions. The GC-A constructs lacking the kinase-like domain (FLAG-@KIN), the guanylate cyclase domain (FLAG-@CYC), the intracellular domain (FLAG-@KC), and the construct consisting of the soluble intracellular domain (FLAG-IN) have been described previously (15) . Two days after transfection, cells were processed for immunoprecipitation and immunoblotting as described above.
RESULTS
Effect of geldanamycin on ANP-stimulated cyclic GMP production -In order to test whether hsp90 was involved in the processing of the ANP receptor, GC-A, we treated 293 cells overexpressing FLAG-tagged GC-A with geldanamycin, an inhibitor of hsp90 function. We have previously shown that FLAG-tagged GC-A is functionally indistinguishable from the untagged receptor (15) . Cells were treated overnight with the indicated concentrations of geldanamycin, and GC-A function was assessed by measuring ANP-stimulated cyclic GMP production in intact cells. As shown in These results suggested that hsp90 is important for GC-A function. (Fig. 2) . Hsp90 was co-immunoprecipitated with the FLAG-tagged GC-A in the absence of geldanamycin, but the complex between GC-A and hsp90 was disrupted following treatment with geldanamycin (Fig. 2) . These data indicated that GC-A was present in a geldanamycin -sensitive complex with hsp90.
Co-immunoprecipitation of hsp90 with GC-
Association of GC-A with hsp70 -The folding pathway for proteins chaperoned by hsp90 normally begins with an association between newly synthesized proteins and hsp70. When transfer of these proteins to an hsp90 complex is blocked by geldanamycin, complexes with hsp70 accumulate (6) . We tested whether this pathway was involved in the folding of GC-A using the co-immunoprecipitation approach described above. FLAG-tagged GC-A was immunoprecipitated from cell lysates with the M2 antibody, and immunoprecipitates were analyzed by Western blotting with an antibody to hsp70. As shown in Fig. 3 Mature hsp90 complexes with protein kinases, on the other hand, contain p50 cdc37 rather than a large immunophilin or PP5 (6,7). We tested which of these co-chaperones was associated with GC-A by co-immunoprecipitation and Western blotting (Figs. 3 and 4) . As shown in Fig. 4,   FKBP51 , FKBP52, Hop, PP5, and p23 were undetectable in FLAG-GC-A immunoprecipitates, in the absence or presence of geldanamycin, though the proteins were readily detected in cell lysates. p50 cdc37 , however, specifically co-immunoprecipitated with GC-A (Fig. 3) . The association between p50 cdc37 and GC-A was disrupted following geldanamycin treatment, much like that between hsp90 and GC-A (Fig. 3) . In that they contained p50 cdc37 and none of the other co-chaperones tested, the hsp90 complexes with GC-A were similar to those associated with protein kinases.
Role of the protein kinase-like domain of GC-A in binding cdc37and hsp90 -GC-A and other
membrane guanylate cyclases contain an intracellular protein kinase-like domain that, though it lacks protein kinase activity, contains most of the conserved residues found in authentic protein kinases (1). Since p50 cdc37 generally functions as a co-chaperone for protein kinases, we hypothesized that the interaction of p50 cdc37 with hsp90 complexes containing GC-A might be mediated by the kinase-like domain. We tested this hypothesis by examining the coimmunoprecipitation of p50 cdc37 with full-length GC-A and with several GC-A deletion mutants. The FLAG-tagged proteins were expressed in COS-7 cells and immunoprecipitated from detergent lysates with the M2 antibody to the FLAG epitope. Immunoprecipitates were then subjected to SDS-PAGE and immunoblotting with an the indicated antibodies. As shown in Fig. 5A , p50 cdc37 co-immunoprecipitated with full-length GC-A, with GC-A lacking its guanylate cyclase catalytic domain, or with the soluble intracellular domain of GC-A.
Immunoprecipitates of deletion mutants lacking the kinase-like domain or lacking the entire intracellular domain did not contain p50 cdc37 (Fig. 5A) . Thus, the kinase-like domain appears to be required for binding of GC-A to p50 cdc37 . The extracellular, transmembrane, and guanylate cyclase domains of GC-A were not required for p50 cdc37 binding. Expression of wild-type GC-A and each of the deletion mutants was confirmed by immunoblotting with M2 ( (17) . We now report that the protein kinase-like domain of GC-A contains a binding site for p50 cdc37 •hsp90 complexes. It seems likely that the association between GC-A and hsp90 is mediated by p50 cdc37 , since this protein has been shown to bind directly to protein kinases (14) . We propose that p50 cdc37 binds to GC-A because the structure of the kinase-like domain of GC-A is similar to that of authentic protein kinases.
The co-immunoprecipitation data presented here are consistent with most models for the folding of client proteins by hsp70, hsp90, and their co-chaperones. GC-A appears, like other proteins, to form complexes with hsp70 and then, in a geldanamycin-sensitive manner, to form a complex with hsp90. As has been shown for other hsp90 client proteins, disruption of this complex by geldanamycin treatment leads to a disruption of GC-A function. We were initially surprised that we did not detect p23, Hop, or large immunophilins in GC-A•hsp90 complexes, and that the only hsp90 co-chaperone we detected was p50 cdc37 . Since p50 cdc37 is thought to be a kinase-specific hsp90 co-chaperone, its association with a membrane guanylate cyclase receptor was unexpected. This association, however, was explained by mapping experiments localizing the site of p50 cdc37 and hsp90 binding to the kinase-like domain of GC-A.
Although the literature tends to draw a clear line between protein kinases forming complexes with hsp90 and p50 cdc37 and other proteins forming complexes with hsp90 and other cochaperones, the reality is probably more complex. A recent report describes the association of two different protein kinases with hsp90 complexes containing not only p50 cdc37 but also the large immunophilin FKBP52 (18) . The precise pathway leading to the final kinase• p50 cdc37 •hsp90 complex is not fully understood. Our data do not establish that these other co-chaperones are not involved in the processing of GC-A; we can only conclude that under the conditions described here we do not detect these proteins in GC-A immunoprecipitates.
Although the processing of proteins via the hsp90 pathway has been best studied using steroid receptors and protein kinases, in recent years it has become clear that a variety of other hsp90 client proteins exist. These include telomerase (19) , nitric oxide synthase (20) , G protein subunits (21) , the cystic fibrosis transmembrane regulator (22) , and now GC-A. GC-A is, to our knowledge, the first protein that is not a protein kinase that is associated with p50 cdc37 in the hsp90 folding pathway. The role of hsp90 and p50 cdc37 in GC-A processing, and the biochemical mechanisms by which these proteins affect GC-A activity, remain to be determined.
It is not clear whether they are involved in the subcellular trafficking of GC-A, in maintaining GC-A in a hormone-activatable conformation, as previously shown for steroid receptors, or in some other function. In the case of one src-family protein kinase, it has been shown that hsp90 is required for the folding of the protein kinase domain, but not for the folding of the SH2 domain (23) . It is possible that the same is true of GC-A, i.e. that hsp90 may be required only for the folding of the kinase-like domain. We believe that hsp90 and p50 cdc37 will be found to play a general role in processing membrane guanylate cyclases. A genetic connection between hsp90 and an olfactory guanylate cyclase in C. elegans was described recently (24) . It will be interesting to determine whether hsp90 and p50 cdc37 are associated with other mammalian membrane guanylate cyclases, and to see whether mutations in p50 cdc37 in other model organisms (25) affect guanylate cyclase function. M2 beads diluted ten-fold with Sepharose 4B. After washes, samples were eluted by heating in SDS sample buffer. Immunoblotting was then performed using monoclonal antibodies to the FLAG epitope (M2), Hop, or p23, and rabbit antisera to FKBP51 or FKBP52. (B) Lysates from the indicated cultures were subjected to immunoprecipitation with undiluted M2 beads. After washes, samples were eluted at 4°C using the FLAG peptide, in order to minimize background staining of IgG heavy chain by the anti-PP5 serum. Immunoblotting was then performed using monoclonal antibodies to the FLAG epitope (M2) or a rabbit antiserum to PP5. For the lysate controls in both panels, an aliquot of the untreated FLAG-GC-A 293 cell lysate was used. 
